The novel anticonvulsant BIA 2-093 inhibits transmitter release during opening of voltage-gated sodium channels: a comparison with carbamazepine and oxcarbazepine.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Neurochemistry International

• Publication date

  2002-04-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0197-0186(01)00101-2PMID 11821151
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Metabolism of two new antiepileptic drugs and their principal metabolites S(+)- and R(-)-10,11-dihydro-10-hydroxy carbamazepine.

  2001cited by this paper
• Excessive release of [3H] noradrenaline by veratridine and ischemia in spinal cord.

  2001cited by this paper
• Inhibition of glutamate release by BIA 2-093 and BIA 2-024, two novel derivatives of carbamazepine, due to blockade of sodium but not calcium channels.

  2001cited by this paper
• Interaction of the Novel Anticonvulsant, BIA 2‐093, with Voltage‐Gated Sodium Channels: Comparison with Carbamazepine

  2001cited by this paper
• The reverse transport of DA, what physiological significance?

  2001cited by this paper
• Anticonvulsant and sodium channel-blocking properties of novel 10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide derivatives.

  1999cited by this paper
• Molecular properties of brain sodium channels: an important target for anticonvulsant drugs.

  1999cited by this paper
• Sodium channels and therapy of central nervous system diseases.

  1997cited by this paper
• Effect of carbamazepine, oxcarbazepine and lamotrigine on the increase in extracellular glutamate elicited by veratridine in rat cortex and striatum

  1996cited by this paper
• Modifications of the Brandel Superfusion 600 system and other revisions in superfusion technique improve the measurement of endogenous dopamine release in vitro.

  1996cited by this paper
• Similar potency of carbamazepine, oxcarbazepine, and lamotrigine in inhibiting the release of glutamate and other neurotransmitters

  1995cited by this paper
• Rat brain neurotransmitter turnover rates altered during withdrawal from chronic cocaine administration.

  1995cited by this paper
• Antiepileptic drug mechanism of action

  1995cited by this paper
• Development of an instrument to assess quality of life in children with epilepsy and learning disability

  1994cited by this paper
• Standard Approach to Antiepileptic Drug Treatment in the United States

  1994cited by this paper
• Effects of oxcarbazepine and 10-hydroxycarbamazepine on action potential firing and generalized seizures.

  1994cited by this paper
• Oxcarbazepine: Preclinical Anticonvulsant Profile and Putative Mechanisms of Action

  1994cited by this paper
• Oxcarbazepine: Mechanisms of Action

  1994cited by this paper
• Antiepileptic Drug Mechanisms of Action

  1993cited by this paper
• Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds.

  1990cited by this paper
• Overflow of endogenous dopamine and 3,4-dihydroxyphenylacetic acid from tissues of the rat brain, elicited by electrical stimulation, depolarization by potassium and activation of carrier-mediated release.

  1990cited by this paper
• A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy.

  1989cited by this paper
• Common Anticonvulsants Inhibit Ca2+ Uptake and Amino Acid Neurotransmitter Release In Vitro

  1987cited by this paper
• Pharmacology of Antiepileptic Drugs

  1987cited by this paper
• Pharmacological Studies on Lamotrigine, A Novel Potential Antiepileptic Drug

  1986cited by this paper
• Pharmacological Studies on Lamotrigine, A Novel Potential Antiepileptic Drug

  1986cited by this paper
• Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures.

  1985cited by this paper
• Inhibition of binding of [3H]batrachotoxinin A 20-alpha-benzoate to sodium channels by the anticonvulsant drugs diphenylhydantoin and carbamazepine.

  1982cited by this paper

• Long-term therapeutic effect of eslicarbazepine acetate in children: An open-label extension of a cognition study in children aged 6-16 years.

  2022cites this paper
• Antiepileptic Drugs Under Investigation for Treatment of Focal Epilepsy

  2016cites this paper
• Review article Newer antiepileptic drugs

  2015cites this paper
• Pharmacokinetic/pharmacodynamic evaluation of eslicarbazepine for the treatment of epilepsy

  2015cites this paper
• Newer antiepileptic drugs

  2015cites this paper
• Recent treatment advances and novel therapeutic approaches in epilepsy

  2015cites this paper
• Clinical utility of eslicarbazepine: current evidence

  2015cites this paper
• Eslicarbazepine acetate: an update on efficacy and safety in epilepsy.

  2014cites this paper
• Eslicarbazepine Acetate: A Review of Its Use as Adjunctive Therapy in Refractory Partial-Onset Seizures

  2014cites this paper
• An efficient synthesis for eslicarbazepine acetate, oxcarbazepine, and carbamazepine

  2013cites this paper
• Evaluation of neurotoxic and neuroprotective pathways affected by antiepileptic drugs in cultured hippocampal neurons.

  2013cites this paper
• STABILITY INDICATING HPLC METHOD FOR THE DETERMINATION OF ESLICARBAZEPINE ACETATE AND ITS IMPURITIES IN BULK DRUGS AND PHARMACEUTICAL DOSAGE FORMS

  2012cites this paper
• Pharmacological Management of Epilepsy

  2012cites this paper
• New antiepileptic drugs

  2012cites this paper
• Pharmacotherapy of the third-generation AEDs: lacosamide, retigabine and eslicarbazepine acetate

  2012cites this paper
• Eslicarbazepine acetate for partial-onset seizures

  2011cites this paper
• Clinical response and tolerability of eslicarbazepine in treatment of partial onset seizures: impact of a novel metabolic pathway

  2011cites this paper
• Eslicarbazepine acetate (BIA 2-093)

  2011cites this paper
• Development of liquid chromatographic enantiomer separation methods and validation for the estimation of (R)-enantiomer in eslicarbazepine acetate.

  2011cites this paper
• Novel Medications for Epilepsy

  2011cites this paper
• Pharmacotherapy of Epilepsy

  2011cites this paper
• Synthesis of S-licarbazepine by asymmetric reduction of oxcarbazepine with Saccharomyces cerevisiae CGMCC No. 2266

  2011cites this paper
• Role of eslicarbazepine in the treatment of epilepsy in adult patients with partial-onset seizures

  2010cites this paper
• Progress report on new antiepileptic drugs: a summary of the Ninth Eilat Conference (EILAT IX).

  2009cites this paper
• Third-generation antiepileptic drugs: mechanisms of action, pharmacokinetics and interactions.

  2009cites this paper
• Treatment of hypersexuality in Parkinson's disease with carbamazepine—A case report

  2009cites this paper
• New and investigational antiepileptic drugs

  2009cites this paper
• Eslicarbazepine acetate: a new option for the treatment of focal epilepsy

  2009influential citation
• Third-generation antiepileptic drugs: mechanisms of action, pharmacokinetics and interactions

  2009cites this paper
• Evidence for pre and postsynaptic nigrostriatal dysfunction in the fragile X tremor–Ataxia syndrome

  2009cites this paper
• Drug assessment based on detection of L-glutamate released from C6 glioma cells using an enzyme-luminescence method.

  2008cites this paper
• Effects of carbamazepine, phenytoin, lamotrigine, oxcarbazepine, topiramate and vinpocetine on Na+ channel-mediated release of [3H]glutamate in hippocampal nerve endings.

  2007cites this paper
• Effect of eslicarbazepine acetate (BIA 2-093) on latrunculin A-induced seizures and extracellular amino acid concentrations in the rat hippocampus.

  2007cites this paper
• Anticonvulsant effect of eslicarbazepine acetate (BIA 2-093) on seizures induced by microperfusion of picrotoxin in the hippocampus of freely moving rats.

  2006cites this paper
• Toward a biaxial model of "bipolar" affective disorders: spectrum phenotypes as the products of neuroelectrical and neurochemical alterations.

  2006cites this paper
• Silent period to transcranial magnetic stimulation: construction and properties of stimulus–response curves in healthy volunteers

  2005cites this paper
• Ion channels as important targets for antiepileptic drug design.

  2004cites this paper
• Progress report on new antiepileptic drugs: a summary of the Seventh Eilat Conference (EILAT VII).

  2004cites this paper
• Dynamic release of amino acid transmitters induced by valproate in PTZ-kindled epileptic rat hippocampus.

  2004cites this paper
• Safety, Tolerability, and Pharmacokinetic Profile of BIA 2‐093, a Novel Putative Antiepileptic, in a Rising Multiple‐Dose Study in Young Healthy Humans

  2004cites this paper
• Phenylarsine oxide inhibits α-latrotoxin-stimulated [3H]GABA release from rat brain synaptosomes

  2003cites this paper
• Safety, Tolerability and Pharmacokinetic Profile of BIA 2-093, a Novel Putative Antiepileptic Agent, during First Administration to Humans

  2003cites this paper
• Phenylarsine oxide inhibits alpha-latrotoxin-stimulated [3H]GABA release from rat brain synaptosomes.

  2003cites this paper